Opportunities to improve life quality of patients with acute coronary syndrome

The pilot randomized prospective comparative study comprised 54 patients with acute coronary syndrome (ACS) with anxiety and depressive disorders. Patients were admitted to the Emergency Department of the Federal State Budgetary Scientific Institution “Research Institute for Cardiology”. Patients were tested for mental status, sleep quality, and quality of life at discharge and after at 6-month follow-up. During conventional therapy of ACS, patients of group 1 (n=27) were administered with Tenoten; patients of group 2 (n=27) were administered with placebo (groups were randomized). Patients had increased level of anxiety and depression at admission. At 6-month follow up, mental status, sleep quality, and quality of life improved in Tenoten group. In placebo group, mental status of patients and sleep quality did not change. The results showed positive effects of Tenoten therapy on mental status, sleep quality, and quality of life.